Comera Life Sciences Holdings, Inc. announced a partnership with Quality Chemical Laboratories, Inc. (QCL) to manufacture one of Comera's lead SQore(TM) excipients, as part of a broader strategy to secure the GMP manufacturing and supply chain of key proprietary technology owned by the Company. Comera is helping companies transform their intravenously administered (IV) biologics into patient delivered subcutaneous (SQ) formulations using a validated and de-risked approach that dramatically reduces time to clinic and commercialization. Comera's proprietary SQore platform integrates computational modeling, a robust library of excipients, and advanced formulation engineering to expedite the development of patient-preferred biotherapeutic formulations, while fostering novel intellectual property creation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0229 USD | -21.71% | -21.84% | -58.36% |
30/01 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
30/01 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
1st Jan change | Capi. | |
---|---|---|
-58.36% | 9L | |
+54.05% | 6.39TCr | |
-2.02% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.87TCr | |
+2.89% | 1.27TCr | |
+22.40% | 1.21TCr | |
+27.49% | 1.21TCr |
- Stock Market
- Equities
- CMRA Stock
- News Comera Life Sciences Holdings, Inc.
- Comera Life Sciences Holdings, Inc. Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients